Skip to main content
. 2003 May;132(2):232–238. doi: 10.1046/j.1365-2249.2003.02142.x

Fig. 5.

Fig. 5

Increase of alveolar macrophage (AM) interleukin-10 (IL-10) production by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). AMs were treated with NNK (100–1000 µM) in the presence of lipopolysaccharide (LPS) (10 ng/ml) for 20 h, and IL-10 was measured in cell-free supernatants. NNK significantly (*P < 0·05) increased IL-10 release by AMs. Mean values ± standard error of the mean (s.e.m.) of six experiments are shown.